Featured CME/CE Courses

• Resource Center

  Clinical Advances in Chronic Obstructive Pulmonary Disease: A Focus on Improving Patient Outcomes Learning Center

• Conference Reporter

  THE ROLE OF PCSK9 INHIBITORS IN LOWERING LDL-C AND REDUCING CARDIOVASCULAR RISK IN PATIENTS WITH DYSLIPIDEMIA

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  CLINICAL ISSUES IN SEVERE ASTHMA: CONSENSUS AND CONTROVERSIES ON THE ROAD TO PRECISION MEDICINE

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast Series

  Breathing Life Into COPD Management: Ongoing Monitoring, Pulmonary Rehabilitation, and Individualized Care

  CREDITS: 0.25 AMA PRA Category 1 Credit™
• Live Meeting

  The Emerging Role of CFTR Combination Regimens in Improving Outcomes for Patients With Cystic Fibrosis

  CREDITS: 1.75 AMA PRA Category 1 Credit(s)™ and 1.75 Nursing Contact Hours
• Webcast

  CYSTIC FIBROSIS INTERVIEW WEBCAST SERIES

  CREDITS: 8 Modules Total - Approx. 0.5 AMA PRA Category 1 Credit™ / CNE Credits Each
• Live Meeting

  How Immune Checkpoint Inhibitors Are Changing the Treatment Landscape for Metastatic Melanoma

  CREDITS: 1.0 AMA PRA Category 1 Credit(s)™
• Conference Reporter

  An Update on Scientific Advances and Clinical Strategies in Migraine

  CREDITS: 1.0 AMA PRA Category 1 Credit(s)™
• Live Meeting

  Spotlight on the Critical Issues in the Treatment of Fabry Disease

  CREDITS: 1.5 AMA PRA Category 1 Credit(s)™
• Webcast

  Current and Future Therapies for Cytomegalovirus (CMV) Infection

  CREDITS: 1.0 AMA PRA Category 1 Credit(s)™
• Webcast

  Irritable Bowel Syndrome: Latest Advances in Pathophysiology, Diagnosis, and Patient Management

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Focus on Uterine Fibroids: Evolving Options to Optimize Care

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Conference Reporter

  Applying New Science to Improve Outcomes for Patients with Multiple Sclerosis

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Developing Optimized Treatment Plans for Patients with Dyslipidemia in the Era of PCSK9 Inhibitor Therapeutics

  CREDITS: 2.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Perspectives from the American Academy of Dermatology 2017 Meeting: Clinical Strategies and Scientific Advances in Atopic Dermatitis

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Severe Asthma and the Primary Care Provider: Identifying Patients and Coordinating Multidisciplinary Care

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™ or 1.00 Nursing Contact Hours
• Interactive Monograph

  Updates in Improving Care of Patients With Rheumatoid Arthritis

  CREDITS: 1.75 AMA PRA Category 1 Credit(s)™
• Supplement

  Immunotherapy: The Wave of the Future in Bladder Cancer?

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Conference Reporter

  An Update on Scientific Advances and Clinical Strategies in Chronic Obstructive Pulmonary Disease (COPD) from the ATS 2017 International Conference

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Caring for Patients with Severe Asthma: Evolving Best Practices to Optimize Outcomes

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis: Refining Approaches to Diagnosis, Prognosis, and Treatment

  CREDITS: 1.25 AMA PRA Category 1 Credit(s)™
• Webcast

  Applying Recent Advances in the Science of CFTR-based Therapeutics to Improve Outcomes in Patients With Cystic Fibrosis

  CREDITS: 2.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Perspectives from the American Academy of Dermatology 2017 Meeting: Clinical Strategies and Scientific Advances in Atopic Dermatitis

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  Real-world Experience With Neuromuscular Blockade Reversal

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Conference Reporter

  An Update on Scientific Advances and Clinical Strategies in Alzheimer’s Disease: Conference Reporter from AD/PD™ 2017

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  REMS Update 2017: Risk Evaluation and Mitigation Strategy

  CREDITS: 3.00 AMA PRA Category 1 Credit(s)™ or 3.0 Nursing Contact Hours
• Webcast

  ACC 2017: A Therapeutic Update to Reduce Risk and Optimize Outcomes for Patients with Reduced or Preserved Ejection Fraction Heart Failure

  CREDITS: 1.00 AMA PRA Category 1 Credit(s)™
• Webcast

  New Considerations for the Treatment of Glioblastoma Multiforme: Evaluating the Potential for Immune Checkpoint Inhibitors

  CREDITS: 1.50 AMA PRA Category 1 Credit(s)™
• Resource Center

  Clinical Advances in Rheumatoid Arthritis Resource Center

• Medical Meeting Reporter

  Clinical Strategies & Scientific Advances in HEPATITIS C VIRUS (HCV)

  CREDITS: 1.25 AMA PRA Category 1 Credit(s)™